Detalhe da pesquisa
1.
Accessory cells precondition naïve T cells and regulatory T cells for cytokine-mediated proliferation.
Proc Natl Acad Sci U S A;
120(15): e2217562120, 2023 04 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37014858
2.
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Blood;
139(10): 1541-1556, 2022 03 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34818414
3.
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.
Proc Natl Acad Sci U S A;
112(42): 13045-50, 2015 Oct 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26438866
4.
Phase 1 trial of IL-15 trans presentation blockade using humanized Mikß1 mAb in patients with T-cell large granular lymphocytic leukemia.
Blood;
121(3): 476-84, 2013 Jan 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23212516
5.
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
Blood;
117(6): 1938-46, 2011 Feb 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21106989
6.
Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques.
Blood;
117(18): 4787-95, 2011 May 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21385847
7.
Interleukin-15 augments NK cell-mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies.
Blood Adv;
7(3): 384-394, 2023 02 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35475910
8.
Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia.
Blood;
116(26): 5948-56, 2010 Dec 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20858854
9.
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma.
Blood Adv;
6(7): 2346-2360, 2022 04 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35030628
10.
Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia.
Transl Oncol;
14(1): 100913, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33129109
11.
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies.
J Immunother Cancer;
9(4)2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33883258
12.
Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.
Blood;
111(10): 5163-72, 2008 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18339896
13.
90Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma.
Cancer Biother Radiopharm;
35(4): 249-261, 2020 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32275165
14.
A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.
Leuk Lymphoma;
: 1-4, 2024 Mar 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38459780
15.
Clinical trial of a humanized anti-IL-2/IL-15 receptor ß chain in HAM/TSP.
Ann Clin Transl Neurol;
6(8): 1383-1394, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31402625
16.
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion.
Clin Cancer Res;
25(16): 4945-4954, 2019 08 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31142503
17.
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.
Cancer Cell;
34(2): 286-297.e10, 2018 08 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30057145
18.
IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities.
Cancer Immunol Res;
5(10): 929-938, 2017 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28842470
19.
Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
J Clin Oncol;
33(1): 74-82, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25403209
20.
Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.
J Mol Diagn;
13(6): 583-604, 2011 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21871973